Phathom Pharmaceuticals Reports Q2 2026 Quarterly Results

What Happened

• Phathom Pharmaceuticals, Inc. announced its financial results for the quarter ended June 30, 2026, by issuing a press release dated July 30, 2026. The press release is attached to the company’s Form 8-K as Exhibit 99.1 and is incorporated by reference in the filing.

Key Details

• Filing date: July 30, 2026 (Form 8-K, Item 2.02: Results of Operations and Financial Condition).
• Period covered: quarter ended June 30, 2026 (Q2 2026).
• Exhibit included: Press release attached as Exhibit 99.1; interactive XBRL cover page data included as Exhibit 104.
• Legal note: Per General Instruction B.2 of Form 8-K, the information (including Exhibit 99.1) is furnished, not “filed” for purposes of Section 18 of the Securities Exchange Act and is not automatically incorporated by reference into other filings.

Why It Matters

• The press release contains the company’s latest quarterly earnings and related financial information investors use to evaluate performance (revenue, net loss/profit, cash position, and any management commentary or guidance). Retail investors should read Exhibit 99.1 to see the specific figures and management discussion.
• Because the information is furnished (not “filed”), it has limits under Section 18 of the Exchange Act for liability and is not automatically incorporated into future securities filings unless expressly referenced.